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Determination of residue levels of alphachloralose in duck tissues
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Abstract: Alpha-chloralose (AC) is used to capture nuisance waterfowl so that they can be
relocated. Concerns for food safety limit its use prior to or during the waterfowl hunting season.
To determine its half-life in tissue, we administered AC to adult male (n = 7) and female (n =
5) mallard ducks (Anas platyrhynchos) via oral gavage. A gel capsule containing 100 µCi of
radioactive AC (14C-AC) and sufficient nonlabeled AC to produce a dose of approximately 30
mg/kg was given to each duck.The ducks were euthanized at 2, 6, 10, and 18 hours postdosing (n = 3 per exposure period), and tissue samples were collected for radioactive analysis.
Residues observed in edible tissues from ducks dosed with radioactive AC demonstrated a
delayed uptake as the duck was under the anesthetic effects of the AC. Following the period
when the ducks were unconscious, most of the AC was rapidly excreted from the body with
mean half-life (t½) values of 9.0 hours, 9.8 hours, and 9.1 hours for breast muscle, liver, and
skin, respectively. An approximation of total excretion (99%) was made by taking 7 times the
t½, resulting in values of between 27 to 33 hours post-exposure. These results suggest that
tissues from mallard ducks are safe for human consumption 48 hours after dosing, a period
that is significantly shorter than the FDA-required 30-day withdrawal period.
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Removal or relocation of nuisance wildlife
is a continuing problem that is being addressed
by the U.S. Department of Agriculture’s (USDA)
Animal and Plant Health Inspection Services
Wildlife Services (WS). Humane removal or
relocation of nuisance birds, such as Canada
geese (Branta canadensis) and various species of
ducks, continues to be a primary goal of WS.
One tool available for the removal of these
birds is an immobilizing drug known as alphachloralose (AC; Borg 1955, Belant et al. 1999).
The drug is a chlorinated acetal derivative of
glucose prepared by condensing chloral with
pentose or hexose sugars in the presence of
sulfuric acid. It has been in use as a human and
veterinary anesthetic since the 1890s (Hanriot
and Richet 1893). Although the specific mode
of action of AC is not fully understood, it is
assumed to cause depression of the cortical
centers of the brain (Williams 1966, Lees 1972,
Silverman and Muir 1993), but at low doses it
also produces some hyperexcitability (Balis and
Monroe 1964).
In 1992, the U.S. Food and Drug
Administration (FDA) granted WS permission

to use AC under an Investigational New
Animal Drug application to capture waterfowl
(Anatidae spp.), pigeons (Columba livia), and
American coots (Fulica americana). Sandhill
cranes (Grus canadensis) and common ravens
(Corvus corax) were allowed by the FDA at a
later date (Woronecki et al. 1992, O’Hare et al.
2007).
Widely used by the WS program to control
pest populations of geese, such as Canada
geese due to the absence of relevant excretion
data, AC use is limited by a default moratorium
for use 30 days before and during waterfowl
hunting season. Birds captured within 30 days
of or during open hunting season must either
be euthanized or held in captivity for 30 days
prior to release. An absorption, distribution,
metabolism, and excretion (ADME) study
conducted with radio-labeled AC is critical for
generating data to determine a science-based
use restriction period that protects food safety.
If all AC derived residues are excreted prior to
30 days post dosing, it is likely that these data
can be used to justify a reduction in the length
of the pre-hunting season moratorium on AC
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use. Also, if AC residues never reach significant
concentrations in edible tissues, it may be
possible eliminate the moratorium.
The objective of this study was to administer
AC to mallard ducks (Anas platyrhynchos) and
euthanize them at selected times post-dose
and analyze edible tissues (breast muscle,
liver, and skin) to determine residue levels.
The data would be used to generate a half-life
of elimination and to evaluate potential risk to
humans from consumption of these tissues.

Research Center (NWRC) Animal Care and Use
Committee (Protocol QA-1465).

Sample collection

The test material for this study was AC
obtained from TCI Chemicals (CAS# 15879-933; Lot# AT01; Tokyo, Japan). The material was
a mix of the alpha and beta isomers and had
a certified purity of 89.7%. The radiolabeled
AC contained only the alpha-isomer and
was ubiquitously labeled on the glucose ring
([glucosyl-14C(U)]-alpha-chloralose; 283 mCi/
mmol; 99% radiochemical purity; Perkin Elmer,
Waltham, Mass.). The beta isomer of chloralose
does not have significant narcotic activity and
does not contribute to the dose delivered to
each duck.

The time course was selected based on
previous experiments that demonstrated that
greater than 95% of AC in the feces of exposed
ducks was excreted within 24 hours post dose
(D. A. Goldade, National Wildlife Research
Center Study Protocol QA-1060, unpublished
report). For each time period (2, 6, 10, and 18
hours), 14C-AC was administered to 3 ducks
of mixed genders, as described in the section
above, as a single dose. At the conclusion of
each exposure time, the ducks were removed
from their cages and euthanized via exposure
to CO2. Samples of breast muscle, liver and skin
were removed from each duck. Tissue samples
were cut into pieces <3-cm-long and placed in
a -80° C ± 5° C freezer until frozen completely
(typically for 2 to 3 hours). Each tissue sample
was removed from the freezer and placed in
a cold stainless steel Warring blender with
between 1 and 2 times its weight of dry ice.
The sample was blended to a powder and
transferred to a Nalgene™ bottle of sufficient
size to contain the entire sample.

Test organism

Liquid scintillation counting analysis

AC was administered to adult male (n = 7) and
female ( n = 5) mallard ducks via oral gavage.
The ducks were obtained from a commercial
supplier and held in quarantine for 2 weeks
prior to the start of the study. Each duck was
weighed prior to receiving a dose of AC to
ensure delivery of the correct dose. Average
mass (±SD) of test animals was 1.2 ± 0.13 kg.

Samples of breast muscle, liver, and skin
were analyzed for extractable and total
radioactive content. For the extractable fraction
analysis, breast muscle, liver, and skin samples
were removed from the freezer and weighed
immediately to preserve them in a frozen state.
A 1.0 g aliquot was weighed into a 10-mL screw
cap glass test tube. Samples were extracted
sequentially with acetonitrile (ACN), 0.1N
hydrochloric acid (HCl), and 6N HCl.
Aliquots of the ACN, 0.1N HCl, and 6N
HCl extracts were taken and placed into
individual 20-mL plastic scintillation vials.
Scintillation cocktail (20 mL of Scintiverse
BD, Fisher Chemicals, Fair Lawn, N.J.) was
added to all extracts, and radioactivity was
determined using a Packard Tri-Carb 1600TR
liquid scintillation counter (LSC; 4-156 kEV;
10-minute count time).

Test material

Methods

Test conditions

A gel capsule containing 100 µCi of 14C-AC
and sufficient nonlabeled AC to produce a
nominal dose of 30 mg/kg body mass was given
to each duck before placing it in a stainless
steel metabolism cage. The stainless steel cage
was placed inside a Plexiglas™ chamber and
sealed shut. Air was delivered to the chamber
by placing a vacuum pump on the exit tube
from the chamber. Birds had free access to
food and water for the duration of the test. All
procedures involving animals were carried Total radioactive analysis
out with the approval of the National Wildlife
A slurry of each sample of tissue was
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Table 1. Mean and standard deviations (n = 3) for
total and extractable alpha-chloralose residue levels
(mg/kg) in tissues of mallard ducks. N.D = not
detectable.
Tissue

Time
(hours)

Breast

Liver

Total

Extractable



SD



SD

2

14.4

1.3

13.6

1.4

6

19.7

1.2

17.6

1.1

10

9.7

1.6

8.3

1.9

18

1.4

0.83

N.D.

2

24.0

3.2

20.9

1.9

6

32.2

1.3

24.1

0.69

Model OX-600 Biological Oxidizer.
Oxygen and nitrogen flows were 350
mL per minute. The combustion and
catalyst zone temperatures were held at
900° C and 680° C, respectively; samples
were combusted for 4 minutes. The CO2
produced was trapped in a 14C cocktail
(R. J. Harvey, Tappan, N.Y.). The cocktail
was transferred to a glass vial and counted
on the LSC. Samples were counted
according to the conditions listed above.

Statistical analysis

The Method Limit of Detection
(MLOD) for each tissue was determined
by following the general procedures
10
21.8
1.3
15.2
2.2
provided by the Environmental Protection
18
5.2
3.7
N.D.
Agency (2011). The data were evaluated
on the basis of concentration of AC
Skin
2
6.9
2.3
6.2
2.0
and metabolites in parts per million of
6
4.4
1.8
6.2
1.5
AC equivalents (Table 1; Figure 1). AC
equivalents are defined as unmetabolized
10
3.3
0.78
3.5
0.71
AC and all metabolites of AC containing
18
0.38
0.22
N.D.
14
C. The results were log-transformed and
subjected to a linear regression analysis.
Results of this transformation were used
to
calculate
elimination constants (KEl) and
prepared by adding deionized water. The
sample slurry was mixed, and an aliquot was terminal half-life of elimination (t½) values for
weighed and combusted in an R. J. Harvey each tissue between 6 and 18 hours post-dose.

Figure 1. Elimination of radio-labeled alpha-chloralose (AC) and metabolites from mallard ducks (Anas platyrhynchos) following a single oral dose (n = 3/time point). Values plotted are means ±1 standard deviation.
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Figure 2. Logarithmic plot of elimination of radiolabeled alpha-chloralose (AC) and metabolites from mallard ducks (Anas platyrhynchos) following a single oral dose (n = 3/time point). Regression lines indicate
the rate of elimination ±1 standard deviation.

The slope of this line yielded the KEl. From this
value, the terminal half-life of elimination was
determined. Because a half-life is commonly
defined as the amount of time it takes for
one-half of the remaining radioactivity to be
excreted from the body, 100% elimination can
never be mathematically achieved. A close
approximation can be found using 7 times the
value of t½. This accounts for elimination of
approximately 99% of the radioactivity.
Mean values from triplicate analyses were
subjected to 2 analyses of variance. A mixed
model (PROC MIXED; SAS, Cary, N.C.) was
used to compare residues among the chemical
extracts. Extract (ACN, HCl, reflux), matrix
(breast, feces, liver, and skin), time (2, 6, 10, and
18 hours), all 2-way interactions, and the 3-way
interaction were fixed effects. Subject was a
random effect.
To compare AC residue data generated by
extraction and combustion, values determined
from all 3 extracts (ACN, HCl, reflux) were first
summed for each sample to yield a total extract
residue concentration. For analysis using a
mixed model, a difference response was then

calculated by subtracting the total extract AC
residue concentration from the combustion
value. Matrix (breast, feces, liver, and skin),
time (2, 6, 10, and 18 hours), and the interaction
were fixed effects. Subject was a random effect.

Exposure estimation
To estimate the magnitude of potential AC
exposure from the consumption of tissues
from AC-treated fowl, the maximum observed
concentrations of total AC derived residues in
breast tissue, liver, and skin were multiplied
by the upper 99th percentile estimate of acute
chicken meat, liver, and skin consumption,
respectively. Human chicken consumption
statistics were obtained from the USDA National
Health and Nutrition Examination Survey
(NHANES 2001 to 2006) using SUDAAN Proc
DESCRIPT. To determine the potential for any
adverse effects associated with consumption of
AC residues in poultry, the estimated exposures
were compared to the estimated acute human
oral no observed effect level (NOEL) of 0.13
mg AC/kg body weight. Human NOEL was
estimated by applying uncertainty factors
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Table 2. Linear regression statistics for log transformed elimination of alpha-chloralose from mallard ducks (Anas platyrhynchos) for exposure time 6 hours to 18 hours.
S.E.

KEl

t½
(hours)

95% C.I. of t½
(hours)

99% Elimination (hours)

0.00003

0.0108

0.235

9.0

8.4–9.9

27

-0.0791

0.002

0.0169

0.182

9.8

8.6–14

33

-0.0977

0.0009

0.0179

0.225

9.1

8.2–11

28

Tissue

R²

Slope

p

Breast

0.928

-0.102

Liver

0.757

Skin

0.810

of ten for interspecies extrapolation and ten
for conversion of lowest observed effect level
(LOEL) to NOEL to the LOEL for chickens
(13.88 mg/kg bodyweight; Loibl et al. 1988).

Results

The MLOD values determined were between
0.06 and 0.47 µg/g, depending on the tissue.
The elimination of radioactivity from the edible
tissues (breast, liver, and skin) all followed a
similar pattern. Following ingestion of the dose,
the birds became lethargic as their respiration
slowed, and they were rendered unconscious
by the AC. As such, their digestion also slowed
and the time to maximum AC concentration
was delayed. The actual maximal value likely
occurred between 2 and 6 hours post-dose,
as most of the ducks had returned to an alert
state 2 or 3 hours post-dose. Therefore, the
half-life of elimination for AC in these tissues
was calculated using the 6-, 10- and 18-hour
observations only. The results reflect this
treatment of the data and take into account
the delay in uptake of the AC (Table 2). For
any future studies, a time point between 2
and 6 hours might be used to elucidate the
true maximum residue value. The elimination
values for each tissue, as well as the P value
for the slope of the regression lines are given
(Figure 2; Table 2).
The presence of strongly bound residues in
exposed tissues could indicate the presence
of highly reactive metabolites. To assess
any potential tissue-binding of AC, the data
generated from solvent extraction of the tissues
(with ACN, 0.1 N HCl, and 6 N HCl) were
compared to the results from combustion
of the same tissues. An ANOVA procedure
was used to evaluate the difference between
bound and extractable AC residues at each
time point. Residue values determined by
the 2 methods differed by matrix (P < 0.0001),
but was influenced strongly by time (matrix 

time; P = 0.0002).The main effect of time was
not significant (P = 0.09). In breast tissue, the
combustion value was significantly greater than
the extraction value only at time 6 (P = 0.01).
In liver, the combustion values were greater
at all times (P < 0.0001). In skin, the extraction
value was greater only at time 6 (P = 0.04). In
all cases, by 16 hours post-dose the extractable
content had decreased below MLOD levels
and was only detectable via the more sensitive
combustion analysis technique (Table 1).
All fixed effects were significant (P < 0.0001)
except for time (P = 0.05) and time  extract
(P = 0.07). Owing to the significant extract 
matrix  time interaction, the differences in
extractable residues for the edible tissues also
demonstrated some interesting characteristics.
In all 3 tissues, most of the extractable AC was
found in the ACN extract. Smaller amounts
were extracted in the subsequent 0.1 N HCl
extraction. No additional radioactivity was
found in the 6 N HCl reflux extraction of skin
samples. There were detectable residue levels
in reflux samples from breast muscle at the 6and 10-hour time points. Significant residues
were found in the liver at the 2-, 6-, and 10-hour
time points in all 3 extracts. These residue levels
were noticeably more concentrated than in any
other tissue.

Discussion

The selected dose of AC (30 mg/kg) was
representative of a dose that might be received
by a bird in an actual field capture scenario
(NWRC SOP WRC-284.R1, Preparing alphachloralose treated grain and bread baits for
field trials involving waterfowl and other birds,
1992, unpublished data). The published LD50
for the test species is 54.6 mg/kg (Williams
1966). No mortalities were observed during the
experiments.
Following AC administration, ducks were
carefully observed. A very rapid loss of motor
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control and lethargy was observed in all of the
test animals. To minimize errors in preparation
of the dose, the total mCi of radioactive AC
was held constant for each experiment. The
radioactive dose was sufficient to produce a
detectable signal with as little as 1% of the dose
present in any tissue analyzed.
The estimated upper bounds of AC exposure
due to consumption of AC-treated fowl breast
tissue (Table 1) was 0.081 mg AC/kgbw per
day. The potential additional consumption
of poultry skin would contribute ≤0.005 mg
AC/kgbw per day. This combined (meat and
skin) upper bound exposure is less than the
estimated human acute oral no-effect level
for AC. Estimated upper bound AC exposure
from consumption of liver from AC treated
fowl was less than the AC exposure associated
with breast tissue consumption. As one would
expect human ingestion of AC treated fowl
to be infrequent, comparison of the upper
bounds exposure estimate with the estimated
acute human no-effect level of 0.13 mg AC/kg
bodyweight suggests that the risk of adverse
effects due to consumption of AC treated
fowl approaches zero. Further, this worst
case assessment assumed that the AC-derived
residues were intact AC. It is likely that <10% of
the tissue residues are AC, with the remainder
being less potent metabolites. This suggests the
probability of AC associated adverse effects
from the consumption of AC treated poultry is
of no public health concern.
The residues observed in edible tissues from
ducks dosed with radioactive AC demonstrate
a delayed uptake as the duck is under the
effects of the AC and exposure from consuming
treated ducks during this time period would
be expected to be quite high. Following the
duck regaining consciousness, most of the
AC and metabolites are rapidly excreted from
the body, with nearly 100% being excreted by
27 to 33 hours after exposure. The magnitude
of AC-derived residues suggests that the
risk of adverse effects due to consumption
of AC treated fowl is negligible at the end of
the excretion period. These results support
shortening the 30-day moratorium on use of
AC to a much shorter duration.
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